How Semaglutide Works: The Breakthrough Weight-Loss Drug

Walk into any urban clinic in India today and you will hear one name migrating from endocrinology journals to dinner-table conversation: semaglutide, the breakthrough weight-loss drug.

Since the drug's Indian patent expired on March 20, 2026, generics from Dr. Reddy's, Sun Pharma, and Natco have entered the market at 50–80 percent below branded pricing — Rs 900–2,000 per month versus Wegovy's earlier Rs 16,400.

But most patients still have only a hazy picture of what semaglutide actually does. 

Biology & Mechanism of Action  

What is Semaglutide? The GLP-1 Receptor Agonist Explained   

Every time you eat, cells in your small intestine release glucagon-like peptide-1 (GLP-1) — a hormone that signals the pancreas to release insulin, slows stomach emptying, and tells the brain calories have arrived. The problem: natural GLP-1 lasts roughly two minutes before an enzyme destroys it. Novo Nordisk's chemists attached a fatty acid chain and swapped a single amino acid to create semaglutide, extending the half-life to ~165 hours. One weekly injection. That is the core engineering insight behind the GLP-1 receptor agonist class. 

The Science of 'Food Noise': How Semaglutide Changes Brain Chemistry 

The most consistent patient report is not measured in kilograms — it is the quiet that descends over the near-constant mental chatter about food. GLP-1 receptors sit in the nucleus accumbens, the brain's reward hub. Semaglutide activates them, reducing the motivational pull of food. Patients don't feel deprived; food becomes less interesting. Neuroimaging studies show reduced activity in the insula and orbitofrontal cortex — the craving centres — when participants on semaglutide view pictures of food. This is fundamentally different from older stimulant-based appetite suppressants. 

Slowed Gastric Emptying: Why You Feel Fuller, Longer 

Semaglutide also activates GLP-1 receptors along the vagus nerve, slowing gastric emptying — a meal that clears the stomach in 90 minutes normally can take three to four hours. That prolonged distension keeps 'still full' signals running to the brain. It also explains the most common side effect: nausea, which peaks during dose escalation and typically resolves within 4–8 weeks at a stable dose. 

Also Read: Oral GLP-1 Drugs: Expanding Patient Access in Obesity and Diabetes Care

Insulin Regulation: Blood Sugar, Appetite, and the Set-Point Reset 

Unlike older diabetes drugs, semaglutide triggers insulin release only when blood glucose is elevated — the glucose-dependent mechanism that keeps hypoglycaemia risk low. It also suppresses glucagon, preventing the blood-sugar spikes and reactive crashes that drive mid-afternoon hunger. The cumulative effect is a recalibration of the body's defended weight set-point — not brute-force willpower, but a quieter biological reset.